Ligand Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Amgen USD 20.48B 2.53B 2025-06
Arrowhead Research USD 194.53M 26.01M 2025-06
Baxter International USD 3.48B 3.03B 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Glaxosmithkline GBP 20.38B 1.32B 2025-06
Insmed USD 311.68M 72.45M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Ligand Pharmaceuticals USD 64.73M 6.05M 2025-06
MacroGenics USD 39M 16.53M 2025-06
Merck USD 26.04B 863M 2025-06
Pacira USD 313.16M 1.57M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Veracyte USD 76.43M 1.31M 2025-06


Ligand Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.